Ted Okon

Ted Okon is a nationally recognized expert on the policy and politics of cancer care. He is quoted extensively in the press, including guest appearances on TV and radio news shows. Ted has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, pharmacy benefit managers (PBMs), drug shortages, and the changing landscape of cancer care delivery in the United States.

Ted has dedicated his career to healthcare business and policy. He has worked for several pharmaceutical companies including Merck and Warner-Lambert, now part of Pfizer, and IMS Health. He co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies (an oncology clinical research network and an information network) and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.

As executive director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. Ted also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.

Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife Susan practiced as a certified oncology nurse.

Bobbi Buell

Bobbi Buell, MBA

Roberta L. Buell is a Principal for Provider Services & Reimbursement Information for onPoint Oncology Inc., a Division of RxVantage, and is a nationally recognized expert in coding and billing. For the last 30 years, she has worked almost exclusively with cancer therapy access--billing, coding and reimbursement for drug therapies. Her newsletter, The E-Reimbursement News, is read by nearly 4000 subscribers each month.

Until July 1, 2003, Ms. Buell was President & CEO of Documedics, which is now part of Amerisource Bergen.  Documedics had contracts to provide reimbursement services including hotlines, financial counseling, alternative reimbursement search, and consulting to over fifteen pharmaceutical and biotech companies in oncology and other specialty drugs.

Ms. Buell started her career in clinical administration at Barnes Hospital-Washington University School of Medicine, Massachusetts General hospital, and Stanford University Medical Center as well as having been a Senior Consultant for Deloitte & Touche and Director, Case Mix Services for Ernst & Young.

Ms. Buell received her BA degree from the University of Wisconsin, Madison, and her MBA degree from Stanford University Graduate School of Business, Palo Alto, California. 

Connie Suen

Connie Suen is the Director of Clinical Services at McKesson and a distinguished Board-Certified Clinical Oncology Pharmacist, whose career is characterized by an exceptional blend of clinical expertise, innovative research, and operational leadership. With a Doctor of Pharmacy degree and specialized post-graduate training in Oncology focusing on Hematopoietic Transplants and Cellular Therapies from Penn Medicine, Connie has amassed extensive experience in both community-based oncology practices and hospital pharmacy environments.

Connie's professional journey began with a profound commitment to optimizing medication use and enhancing patient outcomes. Over the years, she has adeptly navigated multiple facets of oncology pharmacy, from overseeing large-scale pharmacy operations to providing direct clinical support in both inpatient and ambulatory settings. Her role in community oncology and multispecialty practices has been pivotal in guiding providers and practice administrators in the implementation of cutting-edge drug therapies, ensuring alignment with best practices, and maintaining compliance with stringent federal and state regulations.

In addition to her clinical and operational accomplishments, Connie is an active member of several professional organizations, such as the American Society for Transplantation and Cellular Therapy (ASTCT). She serves on various advisory boards and committees, contributing her expertise to shape the future of oncology pharmacy practice. Connie's unique blend of clinical expertise, operational acumen, and unwavering dedication to patient care positions her as a leading figure in the field of oncology pharmacy. Her ability to bridge the gap between clinical initiatives and operational complexities, coupled with her commitment to continuous learning and innovation, makes her a sought-after voice and a respected leader in the healthcare community.

Residing in Pennsylvania with her husband and their one-year-old son, Connie balances her professional life with a passion for travel and cultural exploration.

Eileen Campetti

Master’s of Health Science from Drexel University

Board certified Physician Assistant with a specialty in Gynecologic Oncology 

Current role; Associate Director of Clinical Oncology at Flatiron Health 

Responsibilities within Flatiron; serve as an integrated partner in the development of technology that supports safe and high quality cancer care; with a specific focus on improving care documentation, accelerating care team efficiency,  and enabling practice financial success